Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
{{output}}
Background & aims: Current guidelines recommend a 2-step approach for risk stratification in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) with Fibrosis-4 index (FIB-4) followed by liver stiffness... ...
